Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioTime offers discounts to warrant holders
Yahoo/AP
Saturday, June 19, 2010 - 11:12am
tags:
BioTime, investors
Genzyme ramps up stock repurchase
bizjournals.com
Saturday, June 19, 2010 - 11:10am
tags:
Genzyme, investors
Cytokinetics: Warming Up or Cooling Off?
Motley Fool
Saturday, June 19, 2010 - 11:09am
tags:
Cytokinetics, investors
Qiagen-Genome Add New HLA Tests
Yahoo/Zacks
Saturday, June 19, 2010 - 11:09am
tags:
Qiagen, Genome Diagnostics, human leukocyte antigen
Novartis wins FDA nod for broader Tasigna use
Fierce Pharma
Friday, June 18, 2010 - 11:48am
tags:
Tasigna, Novartis, cancer, FDA, Gleevac
San Diego's Neurocrine Biosciences Scores Second Big Deal in Two Days
Motley Fool
Friday, June 18, 2010 - 11:46am
tags:
Neurocrine, Abbott Laboratories, diabetes, Boehringer Ingelheim, endometriosis
Mylan receives FDA OK for generic version of Zocor
Yahoo/AP
Friday, June 18, 2010 - 11:45am
tags:
FDA, Mylan, cholesterol, generics, Zocor
Drugmakers Prodded by FDA for More Neglected Disease Medicines
Bloomberg Businessweek
Friday, June 18, 2010 - 11:35am
tags:
orphan drugs, Roche, JNJ, Biogen Idec
Amgen’s Bone Drug Wins Positive Review From U.K. Cost Agency
Bloomberg
Friday, June 18, 2010 - 11:32am
tags:
Prolia, UK, Amgen, osteoporosis
Biotech Race for $1B in Government Money Begins Monday
BNET Pharma
Friday, June 18, 2010 - 11:28am
tags:
funding, biotech, grants
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Friday, June 18, 2010 - 11:28am
tags:
Roche, Amylin, Alkermes, diabetes, taspoglutide
Managed Care Has More Faith in the Big Pharma Model Than Big Pharma Does
InVivo
Friday, June 18, 2010 - 9:31am
tags:
managed care, Big Pharma, Quintiles
Sanofi Drops Most in Month on Concern Diabetes Drug May Raise Cancer Risk
Bloomberg
Friday, June 18, 2010 - 9:28am
tags:
Lantus, diabetes, Sanofi
FDA Warns Drug Makers On Misleading Promotional Efforts
NASDAQ.com
Friday, June 18, 2010 - 8:17am
tags:
FDA, warnings, Cumberland, Auxilium, Dainippon Sumitomo, Eisai
Medicare mulls new restrictions on anemia meds
Fierce Pharma
Friday, June 18, 2010 - 7:52am
tags:
Medicare, anemia, JNJ, Epogen, Procrit, Amgen, Aranesp
Roche Expects Delay to Taspoglutide on Safety Concern
Bloomberg
Friday, June 18, 2010 - 7:40am
tags:
Roche, taspoglutide, diabetes
FDA approves Sanofi-Aventis prostate cancer drug
Yahoo/AP
Friday, June 18, 2010 - 7:39am
tags:
FDA, prostate cancer, Sanofi, Jevtana
Mylan says FDA clears generic version of Atarax
Yahoo/AP
Friday, June 18, 2010 - 7:38am
tags:
Atarax, generics, FDA, Mylan, Teva Pharmaceuticals, anxiety
Orexigen says FDA sets Jan. 31 date for Contrave
Yahoo/AP
Thursday, June 17, 2010 - 11:03pm
tags:
FDA, Contrave, Orexigen, obesity
Adolor says pain drugs failed in midstage trial
Yahoo/AP
Thursday, June 17, 2010 - 11:02pm
tags:
Adlor, clinical trials, painkillers

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.